Novel and Emerging Analgesics

This publication has 27 references indexed in Scilit:

• Suzetrigine: First Approval
  Drugs, 2025
• Suzetrigine: A New Analgesic Approved by the FDA
  Topics in Pain Management, 2025
• Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain
  Pain and Therapy, 2025
• Structural mapping of Nav1.7 antagonists
  Nature Communications, 2023
• Review of the ASA Physical Status Classification: Reply
  Anesthesiology, 2022
• Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow
  Acta Pharmacologica Sinica, 2019
• Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists
  Regional Anesthesia & Pain Medicine, 2018
• SCN9A Variants May be Implicated in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy and Pain Severity
  The Clinical Journal of Pain, 2015
• Ketamine Inhibits Sodium Currents in Identified Cardiac Parasympathetic Neurons in Nucleus Ambiguus
  Anesthesiology, 2002
• L-Arginine Attenuates Ketamine-induced Increase in Renal Sympathetic Nerve Activity
  Anesthesiology, 1994